Fluorine-18 is under investigation in clinical trial NCT00870974 (A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.